202 related articles for article (PubMed ID: 19483650)
1. Immunizations with IFNgamma secreting tumor cells can eliminate fully established and invasive rat gliomas.
Janelidze S; Bexell D; Badn W; Darabi A; Smith KE; Fritzell S; Gunnarsson S; Milos P; Bengzon J; Salford LG; Siesjö P; Visse E
J Immunother; 2009; 32(6):593-601. PubMed ID: 19483650
[TBL] [Abstract][Full Text] [Related]
2. Cure of established, intracerebral rat gliomas induced by therapeutic immunizations with tumor cells and purified APC or adjuvant IFN-gamma treatment.
Siesjö P; Visse E; Sjögren HO
J Immunother Emphasis Tumor Immunol; 1996 Sep; 19(5):334-45. PubMed ID: 8941873
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy with bovine aortic endothelial cells in subcutaneous and intracerebral glioma models in rats: effects on survival time, tumor growth, and tumor neovascularization.
Corsini E; Gelati M; Calatozzolo C; Alessandri G; Frigerio S; De Francesco M; Poiesi C; Parati E; Croci D; Boiardi A; Salmaggi A
Cancer Immunol Immunother; 2004 Nov; 53(11):955-62. PubMed ID: 15449042
[TBL] [Abstract][Full Text] [Related]
4. The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas.
Newcomb EW; Demaria S; Lukyanov Y; Shao Y; Schnee T; Kawashima N; Lan L; Dewyngaert JK; Zagzag D; McBride WH; Formenti SC
Clin Cancer Res; 2006 Aug; 12(15):4730-7. PubMed ID: 16899624
[TBL] [Abstract][Full Text] [Related]
5. The human leukemic T-cell line, TALL-104, is cytotoxic to human malignant brain tumors and traffics through brain tissue: implications for local adoptive immunotherapy.
Kruse CA; Visonneau S; Kleinschmidt-DeMasters BK; Gup CJ; Gomez GG; Paul DB; Santoli D
Cancer Res; 2000 Oct; 60(20):5731-9. PubMed ID: 11059767
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma in brain tumor immunotherapy.
Kane A; Yang I
Neurosurg Clin N Am; 2010 Jan; 21(1):77-86. PubMed ID: 19944968
[TBL] [Abstract][Full Text] [Related]
7. Impaired capacity for upregulation of MHC class II in tumor-associated microglia.
Schartner JM; Hagar AR; Van Handel M; Zhang L; Nadkarni N; Badie B
Glia; 2005 Sep; 51(4):279-85. PubMed ID: 15818597
[TBL] [Abstract][Full Text] [Related]
8. Adoptive immunotherapy of CNS malignancies.
Plautz GE; Shu S
Cancer Chemother Biol Response Modif; 2001; 19():327-38. PubMed ID: 11686021
[TBL] [Abstract][Full Text] [Related]
9. Effects of intracarotid and intravenous infusion of human TNF and LT on established intracerebral rat gliomas.
Liu SK; Jakowatz JG; Pollack RB; Ceraldi C; Yamamoto R; Dett C; Lopez F; Camacho C; Carson WE; Sentovich SM
Lymphokine Cytokine Res; 1991 Jun; 10(3):189-94. PubMed ID: 1883913
[TBL] [Abstract][Full Text] [Related]
10. Synergism between GM-CSF and IFNgamma: enhanced immunotherapy in mice with glioma.
Smith KE; Janelidze S; Visse E; Badn W; Salford L; Siesjö P; Darabi A
Int J Cancer; 2007 Jan; 120(1):75-80. PubMed ID: 17044023
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of systemic radionuclide therapy with p-131I-iodo-L-phenylalanine combined with external beam photon irradiation in treating malignant gliomas.
Samnick S; Romeike BF; Lehmann T; Israel I; Rübe C; Mautes A; Reiners C; Kirsch CM
J Nucl Med; 2009 Dec; 50(12):2025-32. PubMed ID: 19910430
[TBL] [Abstract][Full Text] [Related]
12. Autologous natural killer cell therapy for human recurrent malignant glioma.
Ishikawa E; Tsuboi K; Saijo K; Harada H; Takano S; Nose T; Ohno T
Anticancer Res; 2004; 24(3b):1861-71. PubMed ID: 15274367
[TBL] [Abstract][Full Text] [Related]
13. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
[TBL] [Abstract][Full Text] [Related]
14. IFNγ in combination with IL-7 enhances immunotherapy in two rat glioma models.
Fritzell S; Eberstål S; Sandén E; Visse E; Darabi A; Siesjö P
J Neuroimmunol; 2013 May; 258(1-2):91-5. PubMed ID: 23528658
[TBL] [Abstract][Full Text] [Related]
15. Cure of established GL261 mouse gliomas after combined immunotherapy with GM-CSF and IFNgamma is mediated by both CD8+ and CD4+ T-cells.
Smith KE; Fritzell S; Badn W; Eberstål S; Janelidze S; Visse E; Darabi A; Siesjö P
Int J Cancer; 2009 Feb; 124(3):630-7. PubMed ID: 18972433
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral IL-7 delivery by mesenchymal stromal cells potentiates IFNgamma-transduced tumor cell immunotherapy of experimental glioma.
Gunnarsson S; Bexell D; Svensson A; Siesjö P; Darabi A; Bengzon J
J Neuroimmunol; 2010 Jan; 218(1-2):140-4. PubMed ID: 19914721
[TBL] [Abstract][Full Text] [Related]
17. IGF-I triple helix gene therapy of rat and human gliomas.
Trojan LA; Kopinski P; Mazurek A; Chyczewski L; Ly A; Jarocki P; Nikliński J; Shevelev A; Trzos R; Pan Y; Gitis DJ; Bierwagen M; Czapiewska JL; Wei MX; Michalkiewicz J; Henin D; Popiela T; Evrard F; Kasprzak H; Anthony D; Trojan J
Rocz Akad Med Bialymst; 2003; 48():18-27. PubMed ID: 14737936
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC
Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964
[TBL] [Abstract][Full Text] [Related]
19. Intracerebral interleukin 12 induces glioma rejection in the brain predominantly by CD8+ T cells and independently of interferon-gamma.
Vetter M; Hofer MJ; Roth E; Pircher HP; Pagenstecher A
J Neuropathol Exp Neurol; 2009 May; 68(5):525-34. PubMed ID: 19525900
[TBL] [Abstract][Full Text] [Related]
20. Immunogene therapy as a treatment for malignant brain tumors in young mice.
Glick RP; Lichtor T; Lin H; Tarlock K; Cohen EP
J Neurosurg; 2006 Jul; 105(1 Suppl):65-70. PubMed ID: 16871873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
